Biotheranostics logo

WebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID … WebJan 6, 2024 · Hologic announced late Tuesday its acquisition of Biotheranostics for $230 million, marking the second tuck-in for the medical device maker less than a week into …

Biotheranostics Company Profile - Office Locations, Competitors ...

WebApr 19, 2024 · Biotheranostics Inc. has agreed to pay $2 million to resolve allegations that it submitted and caused the submission of false claims to Medicare for Breast Cancer Index (BCI) tests that were not reasonable and necessary for the diagnosis and treatment of breast cancer, the Department of Justice announced today. Biotheranostics is a … WebFeb 22, 2024 · MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million.Biotheranostics develops and markets two highly differentiated molecular … canes in san angelo https://construct-ability.net

Biotheranostics - Crunchbase Company Profile & Funding

WebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In … WebJun 29, 2024 · Biotheranostics, the company that makes the Breast Cancer Index test, has a Patient Services Team to help you with verifying insurance coverage and understanding any out-of-pocket costs. The company also has a patient assistance program that helps pay for testing. To contact the Patient Services Team, call 1-844-319-8111. http://www.biotheranostics.com/ fist of the blue sapphire

Hologic Completes Acquisition of Biotheranostics, Enabling ... - BioSpace

Category:Biotheranostics, Inc. A Hologic Company

Tags:Biotheranostics logo

Biotheranostics logo

Biotheranostics Announces Chief Commercial Officer

WebBiotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to support personalized disease management in … WebBiotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. The company is based in San Diego, CA and offers testing se rvices through its CLIA-certified, CAP-accredited laboratory that is directly ...

Biotheranostics logo

Did you know?

WebBioTheranostics General Information. Description. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and commercializes proprietary molecular-based diagnostic, prognostic and predictive tests that provide physicians with actionable information to help to guide cancer treatment, … WebBiotheranostics privacy statement. This privacy statement governs your use of Biotheranostics’s website and all information you provide to Biotheranostics on our website. This Notice of privacy practices describes how Biotheranostics may use and disclose individuals’ health information, whether collected on our website or off-line, and …

WebCancerTYPE ID ® is a proprietary molecular assay using RT-PCR to measure expression of 92 genes. To classify the tumor, the gene expression profile is matched to a database of more than 2000 known tumor types and subtypes. Using this technology, CancerTYPE ID ® can identify 50 different tumor types and subtypes, covering >95% of all solid ... http://www.biotheranostics.com/

WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. While we discover and ... Web2 days ago · Biotheranostics Illumina DNA Link Genomic Health, Inc.(Exact Sciences) Cypher Genomics(Human Longevity, Inc.) Life Technologies Corporation(Thermo Fisher Scientific) ...

WebJan 5, 2024 · SPX. +1.87%. Medical technology company Hologic Inc. HOLX, +0.71% said late Tuesday it has agreed to buy privately held Biotheranostics Inc. for $230 million. Biotheranostics, which generated ...

WebApr 1, 2024 · Biotheranostics, Inc. operates a CLIA-certified and CAP-accredited diagnostic laboratory in San Diego, California. Biotheranostics, Inc., is a leading healthcare provider in the oncology field ... can esim be transferredWebFeb 22, 2024 · - Breast Cancer Index ™ Added to National Comprehensive Cancer Network Guidelines to Predict Benefit from Extended Endocrine Therapy - Hologic, Inc. (Nasdaq: … canes in plano txWebThis test is used for clinical purposes, and should not be regarded as experimental or investigational. How this information is used to guide patient care is the responsibility of … canes homestead flWebJun 29, 2024 · Biotheranostics, the company that makes the Breast Cancer Index test, has a Patient Services Team to help you with verifying insurance coverage and … fist of the fleetWebLogin. Log in. Forgot your password? Not Registered? Click here to start the process. fist of the forgottenfist of the blue starWebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ... cane sitting chair